Literature DB >> 25511587

Detection of liposomal cholesterol and monophosphoryl lipid A by QS-21 saponin and Limulus polyphemus amebocyte lysate.

Zoltan Beck1, Gary R Matyas2, Carl R Alving3.   

Abstract

Liposomes containing cholesterol (Chol) have long been used as an important membrane system for modeling the complex interactions of Chol with adjacent phospholipids or other lipids in a membrane environment. In this study we utilize a probe composed of QS-21, a saponin molecule that recognizes liposomal Chol and causes hemolysis of erythrocytes. The interaction of QS-21 with liposomal Chol results in a stable formulation which, after injection into the tissues of an animal, lacks toxic effects of QS-21 on neighboring cells that contain Chol, such as erythrocytes. Here we have used liposomes containing different saturated phospholipid fatty acyl groups and Chol, with or without monophosphoryl lipid A (MPLA), as model membranes. QS-21 is then employed as a probe to study the interactions of liposomal lipids on the visibility of membrane Chol. We demonstrate that changes either in the mole fraction of Chol in liposomes, or with different chain lengths of phospholipid fatty acyl groups, can have a substantial impact on the detection of Chol by the QS-21. We further show that liposomal MPLA can partially inhibit detection of the liposomal Chol by QS-21. The Limulus amebocyte lysate assay is used for binding to and detection of MPLA. Previous work has demonstrated that sequestration of MPLA into the liposomal lipid bilayer can block detection by the Limulus assay, but the binding site on the MPLA to which the Limulus protein binds is unknown. Changes in liposomal Chol concentration and phospholipid fatty acyl chain length influenced the detection of the liposome-embedded MPLA. Published by Elsevier B.V.

Entities:  

Keywords:  Cholesterol; Limulus amebocyte lysate; Lipid bilayer heterogeneity; Liposomal model membranes; Monophosphoryl lipid A; QS-21 saponin

Mesh:

Substances:

Year:  2014        PMID: 25511587     DOI: 10.1016/j.bbamem.2014.12.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  Immune response to antigen adsorbed to aluminum hydroxide particles: Effects of co-adsorption of ALF or ALFQ adjuvant to the aluminum-antigen complex.

Authors:  Zoltan Beck; Oscar B Torres; Gary R Matyas; David E Lanar; Carl R Alving
Journal:  J Control Release       Date:  2018-02-09       Impact factor: 9.776

2.  Monophosphoryl lipid A-induced activation of plasmacytoid dendritic cells enhances the anti-cancer effects of anti-PD-L1 antibodies.

Authors:  Wei Zhang; Seong-Min Lim; Juyoung Hwang; Srinivasan Ramalingam; Myunghee Kim; Jun-O Jin
Journal:  Cancer Immunol Immunother       Date:  2020-09-09       Impact factor: 6.968

Review 3.  An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives.

Authors:  Alessio Facciolà; Giuseppa Visalli; Antonio Laganà; Angela Di Pietro
Journal:  Vaccines (Basel)       Date:  2022-05-22

4.  Designing Adjuvant Formulations to Promote Immunogenicity and Protective Efficacy of Leptospira Immunoglobulin-Like Protein A Subunit Vaccine.

Authors:  Teerasit Techawiwattanaboon; Thomas Courant; Livia Brunner; Suwitra Sathean-Anan-Kun; Pratomporn Krangvichian; Nutta Iadsee; Yaowarin Nakornpakdee; Noppadon Sangjun; Pat Komanee; Nicolas Collin; Kiat Ruxrungtham; Kanitha Patarakul
Journal:  Front Cell Infect Microbiol       Date:  2022-06-16       Impact factor: 6.073

Review 5.  Army Liposome Formulation (ALF) family of vaccine adjuvants.

Authors:  Carl R Alving; Kristina K Peachman; Gary R Matyas; Mangala Rao; Zoltan Beck
Journal:  Expert Rev Vaccines       Date:  2020-03-31       Impact factor: 5.217

6.  Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants.

Authors:  Robyn Marty-Roix; Gregory I Vladimer; Kimberly Pouliot; Dan Weng; Rachel Buglione-Corbett; Kim West; John D MacMicking; Jonathan D Chee; Shixia Wang; Shan Lu; Egil Lien
Journal:  J Biol Chem       Date:  2015-11-10       Impact factor: 5.157

7.  Lysosome-Dependent Activation of Human Dendritic Cells by the Vaccine Adjuvant QS-21.

Authors:  Iain Welsby; Sophie Detienne; Francisca N'Kuli; Séverine Thomas; Sandrine Wouters; Viviane Bechtold; Dominique De Wit; Romain Gineste; Thomas Reinheckel; Abdelatif Elouahabi; Pierre J Courtoy; Arnaud M Didierlaurent; Stanislas Goriely
Journal:  Front Immunol       Date:  2017-01-05       Impact factor: 7.561

8.  The 2017 Keystone Symposium on HIV Vaccines.

Authors:  Christopher A Cottrell; Andrew B Ward
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

9.  Liposome Consolidated with Cyclodextrin Provides Prolonged Drug Retention Resulting in Increased Drug Bioavailability in Brain.

Authors:  En-Yi Lin; Yu-Shuan Chen; Yuan-Sheng Li; Syuan-Rong Chen; Chia-Hung Lee; Mao-Hsuan Huang; Hong-Meng Chuang; Horng-Jyh Harn; Hsueh-Hui Yang; Shinn-Zong Lin; Dar-Fu Tai; Tzyy-Wen Chiou
Journal:  Int J Mol Sci       Date:  2020-06-21       Impact factor: 5.923

Review 10.  Liposomes used as a vaccine adjuvant-delivery system: From basics to clinical immunization.

Authors:  Ning Wang; Minnan Chen; Ting Wang
Journal:  J Control Release       Date:  2019-05-03       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.